PE48297A1 - Metodos y composiciones para la prevencion y el tratamiento de desordenes gastrointestinales - Google Patents

Metodos y composiciones para la prevencion y el tratamiento de desordenes gastrointestinales

Info

Publication number
PE48297A1
PE48297A1 PE1996000327A PE00032796A PE48297A1 PE 48297 A1 PE48297 A1 PE 48297A1 PE 1996000327 A PE1996000327 A PE 1996000327A PE 00032796 A PE00032796 A PE 00032796A PE 48297 A1 PE48297 A1 PE 48297A1
Authority
PE
Peru
Prior art keywords
prevention
gastrointestinal disorders
compositions
treatment
methods
Prior art date
Application number
PE1996000327A
Other languages
English (en)
Spanish (es)
Inventor
Jamesina Anne Fitzgerald
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE48297A1 publication Critical patent/PE48297A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PE1996000327A 1995-05-09 1996-05-08 Metodos y composiciones para la prevencion y el tratamiento de desordenes gastrointestinales PE48297A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43747595A 1995-05-09 1995-05-09

Publications (1)

Publication Number Publication Date
PE48297A1 true PE48297A1 (es) 1998-02-04

Family

ID=23736610

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000327A PE48297A1 (es) 1995-05-09 1996-05-08 Metodos y composiciones para la prevencion y el tratamiento de desordenes gastrointestinales

Country Status (6)

Country Link
EP (1) EP0830135A1 (fr)
JP (1) JPH11504940A (fr)
AU (1) AU5733696A (fr)
CA (1) CA2219758A1 (fr)
PE (1) PE48297A1 (fr)
WO (1) WO1996035436A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE288257T1 (de) 1999-04-06 2005-02-15 Ethypharm Sa Trinkbare pharmazeutische suspension von ibuprofen
FR2791888B1 (fr) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005981A1 (fr) * 1985-04-18 1986-10-23 Borody Thomas J Traitement de la dyspepsie non ulcereuse avec des sels de bismuth
DE3686836T2 (de) * 1985-06-13 1993-03-04 Marshall Barry James Zusammensetzungen zur behandlung von magen-darmstoerungen.
EP0439453B1 (fr) * 1987-10-12 1994-01-19 Exomed Australia Pty. Ltd. (ACN 051 976 446) Procede ameliore servant au traitement de troubles gastrointestinaux
ATE184198T1 (de) * 1993-05-11 1999-09-15 Spirig Ag Festes bismut- und amoxycillinhaltiges arzneipräparat und seine verwendung

Also Published As

Publication number Publication date
CA2219758A1 (fr) 1996-11-14
AU5733696A (en) 1996-11-29
EP0830135A1 (fr) 1998-03-25
WO1996035436A1 (fr) 1996-11-14
JPH11504940A (ja) 1999-05-11

Similar Documents

Publication Publication Date Title
TR200102021T2 (tr) TWEAK ve TWEAK reseptörü antagonistleri ve bunların imünolojik bozuklukların iyileştirilmesi için kullanımları
DE69625518D1 (de) Wirkstoff zur behandlung neurodegenerativer störungen
IS1990B (is) Nýstárlegar staðgengnar hringamínósýrur notaðar til lyfjagerðar
ATE284690T1 (de) Antithrombotische diamine
YU67694A (sh) Ne-peptidni antagosnisti receptora tahikinina
BR9908869A (pt) Composição para evitar ou tratar distúrbios da pele
DK1196397T3 (da) Metabotrope glutamatreceptorantagonister og anvendelse deraf til behandling af sygdomme i centralnervesystemet
ES2194960T3 (es) N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
DE60229530D1 (de) Substituierte piperazine als modulatoren des melanocortinrezeptors
DE60228073D1 (de) Adenosin-a1-rezeptorantagonisten zur behandlung von hypoxiebedingten lern- und gedächtnisstörungen
NO983612D0 (no) Nye cykliske aminosyrer som farmasöytiske midler
MX9203050A (es) Compuestos de analogos de triptamina.
DE69921340D1 (de) Verzweigte alkylpyrrolidin-3-carbonsäuren
FI961809A (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
NO944578L (no) Eksitatoriske aminosyre reseptor antagonister
NO976048L (no) Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser
HUP9800731A2 (hu) Eljárás ivarsejt osztódás stimulálására
BR0111892A (pt) Bis-arilsulfonas
BR0010183A (pt) Derivados de monofluoroalquila
DK0989973T3 (da) Chalconer med antiproliferativ aktivitet
PE48297A1 (es) Metodos y composiciones para la prevencion y el tratamiento de desordenes gastrointestinales
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DE60204882D1 (de) Zykloalkenylsulfonamidderivate
ATE210460T1 (de) Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben

Legal Events

Date Code Title Description
FA Abandonment or withdrawal